ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

Venous Thromboembolism and Cardioembolism » Atrial Fibrillation

Theme Navigation

  • ISTH 2020 Congress
    • Venous Thromboembolism and Cardioembolism
      • Atrial Fibrillation

Abstract Number: PB2086

An observational Study of INR Control and Bleeding Events, According to European Society of Cardiology (ESC) Guidelines, in Non-valvular Atrial Fibrillation (NVAF) Stratified by Male and Female Sex

D. Harris1, F. Torabi1, R. Alikan2, A. Akbari1, D. Mallory1, D. Thayer1, T. Wang1, S. Grundy3, S. Lister4, M. Gravenor1, J. Halcox1

Abstract Number: PB2074

Anticoagulant Management Strategies in Cancer Patients with Atrial Fibrillation in Daily Clinical Practice

G. Chu1, M.V. Huisman1, H. Gelderblom2, M.E. Hemels3,4, T. van der Hulle2, S.A. Trines5, F.A. Klok1

Abstract Number: PB2055

Anticoagulation in Non-Valvular Atrial Fibrillation: Old or New Friends?

M.-A. Gaman1, E.-C. Dobrica2, M.-A. Cozma2, C.C. Diaconu3

Abstract Number: PB2069

Anticoagulation Resumption After Intracerebral Hemorrhage in Two Cohorts of Patients Treated with Vitamin K Antagonists and Direct Oral Anticoagulants

D. Poli1, E. Antonucci2, E. Vignini1, L. Martinese1, S. Testa3, G. Guazzaloca4, P. Simioni5, V. Pengo5, P. Pignatelli6, A. Falanga7, L. Masciocco8, D. Barcellona9, A. Ciampa10, P. Chiarugi11, C. Paparo12, E. Bucherini13, M. Marzolo14, W. Ageno15, G. Palareti2

Abstract Number: PB2057

Assessment and Predictors of Inappropriate Dose of Direct Oral Anticoagulants

M. Almegren1, M. Alotaibi2, M. Alghafis2, M. Al-Alwan2, S. Alshehri2, M. Almulla2, L. Zaid2

Abstract Number: PB2080

Association of Body Mass Index (BMI) with Bleeding Events in Patients Taking Oral Anticoagulation for Atrial Fibrillation (AF) or Venous Thromboembolism (VTE)

T. Feldeisen1, X. Kong1, E. Kline-Rogers1, C. Alexandris-Souphis1, B. Haymart1, D. DeCamillo1, S. Kaatz2, M. Ali3, J. Kozlowski4, V. Shah5, G.D. Barnes1, J.B. Froehlich1

Abstract Number: PB2060

Association of Clinical Risk Factors and Biomarkers with Thromboembolism, Major Bleeding, and All-Cause Death in Patients with Atrial Fibrillation in a Tertiary Care Setting

D. Kraemmer, O. Königsbrügge, S. Nopp, I. Pabinger, C. Ay

Abstract Number: PB2088

Atrial Fibrillation Treated with Warfarin at an Academic Medical Center: The Potential Impact of Direct Oral Anticoagulants on Future Management

P. Collins1, A. Lewin1, N. Vincze Irving1, K. Sylvester1, J. Fanikos1, S.Z. Goldhaber2, J.M. Connors3

Abstract Number: PB2079

Beyond the Registry: A Nuanced Evaluation of Real World Anticoagulation for Nonvalvular Atrial Fibrillation Patients at a Tertiary Care Center

G. Woodhouse1, Z. Paschall2, C. Lunowa3, J. Burch1, L. Schilling4, M. Rosenberg5, N. Mantini5

Abstract Number: PB2049

Characterization of VKA Control in Patients with Thrombotic and Major Hemorrhagic Events in Anticoagulation Hematology Units: Results from the EVENTHO Study

O. Gavín1, V. Roldán2, A. Santamaría3, P. Llamas4, D. Arumí5, S. Fernández de Cabo5

Abstract Number: PB2040

Clinical Case: Reversal of Dabigatran Levels in Patients with Renal Insufficiency that Have Required the use of Idarucizumab

A. Tugues Peiró1, C. Marzo Alonzo1, E. Vicente Pascual1, A. Ferrero Campos1, A. Ruiz1, M.E. Rivero1, A. Garcia Guiñon1, A. Luaña1, C. Chavez1, M. Teixido1, X. Gomez2, T. Garcia1

Abstract Number: PB2064

Clinical Outcomes for Patients of High Body Weight on Apixaban or Rivaroxaban

G. Bahra, Z. Mahir, V. Collings, K. Breen, B. Hunt, A. Cohen

Abstract Number: PB2085

Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation

M. Giustozzi1, M. Mazzetti2, M. Paciaroni1, G. Agnelli1, C. Becattini1, M.C. Vedovati1

Abstract Number: PB/LB03

Differences in Outcomes between Real-World vs Clinical Trial in Atrial Fibrillation and Chronic Kidney Disease

W.Y. Ding1, J.M.R. Caravaca1,2, V. Roldán3, G.Y.H. Lip1,4

Abstract Number: PB2051

Differences in Treatment and Outcomes in Recently Diagnosed Atrial Fibrillation between the Netherlands and Belgium: Results from the GARFIELD-AF Registry

J. Seelig1,2, M.E.W. Hemels1,3, O. Xhaët4, M.C.M. Bongaerts5, A. de Wolf6, B.E. Groenemeijer7, A. Heyse8, P. Hoogslag9, J. Voet10, J.P.R. Herrman11, G. Vervoort12, W. Hermans13, B. Wollaert14, L.V.A. Boersma15,16, K. Hermans17, A. Lucassen18, K. Pieper19, F.W.A. Verheugt11, F. Cools20, H. ten Cate2,21, on behalf of the GARFIELD-AF Investigators

Abstract Number: PB2062

Differential Effect of Direct Oral Anticoagulants (DOACs) on Thrombin Generation and Clot Lysis in Patients with Non Valvular Atrial Fibrillation (AF) and Venous Thromboembolism (VTE)

L. Dirienzo1, A. Vitulli1, C.T. Ammollo1, F. Mancazzo1, C. Dellanoce2, O. Paoletti2, S. Testa2, M. Colucci1

Abstract Number: PB2054

Effect of Patient and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) Study

K. MacDougall1, J. Douketis2, N. Li2, N. Clark3, A. Tafur4, J. D'Astous5, J. Duncan2, S. Schulman2, A. Spyropoulos6

Abstract Number: PB2068

Emergency Room Access of Patients on DOACs: A Six Years Single Center Experience

L. Crippa1, L. Pozzi2, L. Tomassini1, P. Della Valle1, E. Pattarini3, A. Fattorini1, A. D'Angelo1

Abstract Number: PB2052

Factor V Leiden Is Associated with Atrial Fibrillation, but Not Ischemic Stroke in Atrial Fibrillation. The Tromsø Study

E.M. Hald1, M.-L. Løchen2, E.B. Mathiesen3, I. Njølstad2, S.K. Brækkan1, J.-B. Hansen1

Abstract Number: PB2065

Fatal Intracerebral Hemorrhage in a Patient on Warfarin: A Case Report

A.B.R. Rosa1, M.F.S. Praxedes2, B.C.S. Almeida1, A.F. Medeiros3, A.L. Ribeiro1, M.A.P. Martins1,4

  • 1
  • 2
  • 3
  • Next Page »

« View all themes from the ISTH 2020 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.